Cg Oncology Profit Margin

The latest profit margin for CGON is -8.15% as of March 2026. That compares with -159.45% in the prior-year period — up 94.9% year over year. That is below the sector sector average of 19.69%. Investors often review this figure alongside Cg Oncology's historical trend and sector peers before judging valuation or financial health.

Over the past year, CGON's profit margin moved from -159.45% to -8.15% — a 94.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cg Oncology's valuation or profitability profile.

Against its sector companies, CGON currently prints -8.15% for profit margin, while the sector average sits near 19.69%. That is roughly 4236.9% below the sector mean. Large gaps often invite a closer look at Cg Oncology's growth, margins, and balance sheet.

Profit Margin shows how effectively Cg Oncology converts resources into returns. At -8.15%, CGON may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -159.45% in the prior-year period — up 94.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CGON's profit margin (-8.15%), review year-over-year change from -159.45%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.